Science&Humans raises $10 million as hormone health enters the mainstream | BetaKit
Toronto startup hopes Series A round will propel it beyond its 60,000 patients. After seven years bootstrapping a telemedicine…
Toronto startup hopes Series A round will propel it beyond its 60,000 patients. After seven years bootstrapping a telemedicine…
UK-based longevity startup GlycanAge has raised €7.4 million ($8.7 million) in fresh funding to accelerate the clinical development of its…